High-purity Bronchogen serves as a pivotal synthetic peptide bioregulator in experimental genomic stability, chromatin dynamics, and DNA thermal denaturation research. Sourcing analytical-grade Bronchogen requires verified sequence fidelity, strict endotoxin control, and documented purity to ensure reproducible results across in vitro and biophysical assays.
High-purity Bronchogen serves as a pivotal synthetic peptide bioregulator in experimental genomic stability, chromatin dynamics, and DNA thermal denaturation research. Sourcing analytical-grade Bronchogen requires verified sequence fidelity, strict endotoxin control, and documented purity to ensure reproducible results across in vitro and biophysical assays.
A reliable bronchogen dna thermostability supplier provides research-grade short peptide bioregulators specifically verified for biophysical and genomic interaction assays. Bronchogen is a synthetic tetrapeptide (Ala-Glu-Asp-Leu) investigated for its capacity to bind site-specifically to DNA double helices, altering chromatin conformation and modulating thermal denaturation profiles ($T_m$) in preclinical models.
PX1 Research supplies high-purity, lyophilized Bronchogen synthesized in USA-based, GMP-compliant facilities. Every batch undergoes rigorous characterization via reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) to guarantee structural identity, precise molecular weight verification, and lot-to-lot consistency required for rigorous in vitro research. Researchers can explore our complete catalog of research peptides to support advanced genomic investigations.
Bronchogen belongs to the short peptide bioregulator class, characterized by low molecular weight oligopeptides derived from organ-specific peptide complexes or designed de novo based on peptide-DNA binding motifs. Composed of the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-leucine, Bronchogen exhibits a net negative charge under physiological pH due to the side-chain carboxyl groups of aspartic acid and glutamic acid.
In biophysical research, short peptide sequences act as site-specific ligands capable of hydrogen bonding and ionic interaction with nucleotide bases and the sugar-phosphate backbone of double-stranded DNA. Preclinical literature indicates that these short motifs possess high conformational flexibility, permitting sequence-selective insertion into the major or minor grooves of duplex DNA. To review primary data on similar bioregulatory sequences, researchers can access the PX1 Research Library.
The primary focus of Bronchogen research in biophysics centers on its influence over DNA thermal stability. Thermal denaturation assays—typically conducted using ultraviolet spectrophotometry at 260 nm or differential scanning calorimetry (DSC)—measure the transition of double-stranded DNA into single-stranded random coils as temperature increases. The midpoint of this melting transition is designated as the melting temperature ($T_m$).
In vitro experiments demonstrate that when Bronchogen interacts with double-stranded genomic DNA or synthetic polynucleotides, it stabilizes the hydrogen bonds between complementary base pairs. Preclinical studies suggest that this interaction shifts the thermal denaturation curve, increasing the $T_m$ value by several degrees Celsius depending on peptide concentration and ionic strength. This elevated thermostability is hypothesized to result from local charge neutralization, structural condensation of the double helix, and inhibition of premature localized unwinding (DNA melting bubbles).
Beyond isolated biophysical assays, Bronchogen is frequently studied in bronchial epithelial cell cultures and organotypic tissue models. Epigenetic investigation indicates that peptide bioregulators modulate gene expression without altering the primary polynucleotide sequence. By binding to complementary DNA motifs in promoter regions, Bronchogen may alter local chromatin accessibility, modulating histone acetylation and RNA polymerase binding affinity.
In vitro data indicate that Bronchogen exposure in cell lines subjected to oxidative stress or thermal shock results in preserved genomic integrity and reduced markers of double-strand DNA breaks. Researchers investigating respiratory cell dynamics utilize analytical-grade Bronchogen peptide to quantify changes in gene expression profiles associated with surfactant synthesis, cellular proliferation, and repair mechanisms in preclinical models.
To contextualize Bronchogen's physical and biological characteristics, laboratory investigators frequently compare it against other short bioregulatory peptides targeting gene expression and chromatin structure. Among these, Epitalon (Ala-Glu-Asp-Gly) is widely studied for its interactions with telomeric DNA sequences and telomerase induction in aging cellular models.
Similarly, research into Vilon (Lys-Glu) focuses on chromatin decondensation and immune system gene regulation, whereas studies evaluating KED Peptide (Lys-Glu-Asp) emphasize vascular and endothelial transcriptomics. While all these compounds interact with the double helix, Bronchogen displays preferential binding patterns toward sequences enriched in promoter regions of bronchial and epithelial cell lines, making it a unique tool for tissue-specific genomic research.
When conducting sensitive DNA thermal denaturation or spectroscopic assays, subtle impurities—such as residual truncation peptides, organic solvents, or heavy metals—can significantly distort $T_m$ readings and circular dichroism (CD) spectra. Sourcing from a verified bronchogen dna thermostability supplier ensures that every lot undergoes comprehensive analytical validation prior to release.
PX1 Research utilizes high-performance liquid chromatography (RP-HPLC) using C18 reverse-phase columns to confirm chromatographic purity exceeding 98.0%. Molecular mass confirmation is performed via electrospray ionization mass spectrometry (ESI-MS) to verify the target mass of 460.44 g/mol. Every order includes a lot-specific Certificate of Analysis (COA) detailing exact purity percentages and spectral data. Institutional laboratories requiring specialized quantities can utilize our wholesale lab account portal for bulk procurement.
Bacterial endotoxins (lipopolysaccharides, LPS) represent a major confounding variable in cellular assays and biophysical experiments. Excessive endotoxin levels induce non-specific inflammatory signaling pathways in cell cultures and interfere with optical density readings in spectroscopic assays.
To eliminate these variables, PX1 Research subjects all peptide lots to quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing. Our research-grade Bronchogen is verified to contain endotoxin levels below 0.01 EU/mg. This level of purity ensures that observed changes in DNA thermal stability, gene expression, or cellular response are directly attributable to the peptide compound rather than exogenous bacterial contaminants.
Proper handling and storage protocols are critical to maintaining the chemical integrity and secondary structure of Bronchogen in laboratory settings. The peptide is supplied as a sterile, lyophilized white powder sealed under inert gas.
For reconstitution, investigators should use sterile, laboratory-grade solvents such as bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or molecular biology-grade water. Reconstitution should be performed by gently swirling the vial; vigorous vortexing should be avoided to prevent mechanical shear stress. Stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles. Lyophilized vials should be stored at -20°C for long-term stability, while reconstituted aliquots remain stable at 2°C to 8°C for up to 7 to 14 days.
Securing high-purity research compounds requires a transparent, traceable supply chain. PX1 Research synthesizes all research peptides within state-of-the-art facilities located in the United States, operating under ISO 17025 accredited testing frameworks and GMP-compliant operational standards.
By maintaining dual dispatch hubs in California and Arizona, PX1 Research provides rapid, same-day dispatch for orders placed before cutoff times (Monday through Friday). Cold-chain packaging options and real-time tracking ensure that temperature-sensitive peptide bioregulators arrive at research institutions without thermal degradation or compromised container closure integrity.
What is Bronchogen used for in laboratory research?
Bronchogen is used in preclinical research to investigate peptide-DNA binding mechanisms, DNA thermal stability (Tm shifts), chromatin conformation changes, and tissue-specific gene expression in respiratory and epithelial cell models.
How does Bronchogen influence DNA thermostability?
In vitro biophysical studies show that Bronchogen binds to the major and minor grooves of double-stranded DNA, stabilizing base pairing and increasing the thermal melting temperature (Tm) measured during UV denaturation assays.
What analytical methods verify PX1 Research Bronchogen purity?
PX1 Research verifies Bronchogen using reverse-phase high-performance liquid chromatography (RP-HPLC) for purity percentages (>98%) and electrospray ionization mass spectrometry (ESI-MS) for accurate molecular mass confirmation.
What are the endotoxin limits for research-grade Bronchogen?
PX1 Research enforces strict endotoxin screening using kinetic chromogenic LAL assays, ensuring endotoxin content remains below 0.01 EU/mg to prevent non-specific cellular signaling or optical assay interference.
How should lyophilized Bronchogen be stored upon delivery?
Lyophilized Bronchogen should be stored in a freezer at -20°C or -80°C away from light and moisture. Under these conditions, the desiccated peptide maintains stability for up to 24 months.
What solvent is recommended for reconstituting Bronchogen in vitro?
Reconstitution is typically performed using sterile laboratory-grade water, phosphate-buffered saline (PBS, pH 7.4), or sterile bacteriostatic water, depending on the requirements of the downstream assay.
Where is PX1 Research Bronchogen manufactured and shipped from?
All PX1 Research peptides are manufactured in USA-based, GMP-compliant facilities and shipped directly from distribution hubs in California and Arizona with same-day dispatch M-F.
Can Bronchogen be used for clinical or therapeutic applications?
No. Bronchogen is supplied strictly as a research chemical compound for laboratory, in vitro, and preclinical research applications. It is not intended for human or animal clinical use, diagnosis, or treatment.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.